Cover Image

Reply to Truffot et al

To the editor - In their letter to Clinical Infectious Diseases, Truffot and coworkers suggest that the recently reported changes in voriconazole dose requirement

Saved in:
Bibliographic Details
Main Authors: Mahmoudi, Mazyar (Author) , Brenner, Thorsten (Author) , Hatiboglu, Gencay (Author) , Burhenne, Jürgen (Author) , Weiß, Johanna (Author) , Weigand, Markus A. (Author) , Haefeli, Walter E. (Author)
Format: Article (Journal)
Language:English
Published: [15 May 2018]
In: Clinical infectious diseases
Year: 2018, Volume: 66, Issue: 10, Pages: 1644-1646
ISSN:1537-6591
DOI:10.1093/cid/cix1099
Online Access:Verlag, Volltext: https://doi.org/10.1093/cid/cix1099
Verlag, Volltext: https://academic.oup.com/cid/article/66/10/1644/4827566
Get full text
Author Notes:Mazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, Jürgen Burhenne, Johanna Weiss, Markus A. Weigand, and Walter E. Haefeli
Description
Summary:To the editor - In their letter to Clinical Infectious Diseases, Truffot and coworkers suggest that the recently reported changes in voriconazole dose requirement
Item Description:Published: 27 January 2018
Reaktion auf: Truffot, A., Thiebaut-Bertrand, A., Chapuis, C., Stanke-Labesque, F., Gautier-Veyret, E.: Inhibition of voriconazole metabolism by meropenem: a role for inflammation?
Gesehen am 16.09.2019
Physical Description:Online Resource
ISSN:1537-6591
DOI:10.1093/cid/cix1099

Similar Items